These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 19953247

  • 1. Re-evaluation of histopathological factors affecting prognosis of differentiated thyroid carcinoma in an iodine-sufficient country.
    Sugitani I, Toda K, Yamamoto N, Sakamoto A, Fujimoto Y.
    World J Surg; 2010 Jun; 34(6):1265-73. PubMed ID: 19953247
    [Abstract] [Full Text] [Related]

  • 2. Long-term outcome of differentiated thyroid carcinoma: experience in a developing country.
    Bhargav PR, Mishra A, Agarwal G, Agarwal A, Pradhan PK, Gambhir S, Verma AK, Mishra SK.
    World J Surg; 2010 Jan; 34(1):40-7. PubMed ID: 20020292
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Global variation in the pattern of differentiated thyroid cancer.
    Woodruff SL, Arowolo OA, Akute OO, Afolabi AO, Nwariaku F.
    Am J Surg; 2010 Oct; 200(4):462-6. PubMed ID: 20887838
    [Abstract] [Full Text] [Related]

  • 5. Differentiated thyroid carcinoma that express sodium-iodide symporter have a lower risk of recurrence for children and adolescents.
    Patel A, Jhiang S, Dogra S, Terrell R, Powers PA, Fenton C, Dinauer CA, Tuttle RM, Francis GL.
    Pediatr Res; 2002 Nov; 52(5):737-44. PubMed ID: 12409522
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival.
    Lo CY, Chan WF, Lam KY, Wan KY.
    Ann Surg; 2005 Nov; 242(5):708-15. PubMed ID: 16244545
    [Abstract] [Full Text] [Related]

  • 9. Comparison of Survival Outcomes Following Postsurgical Radioactive Iodine Versus External Beam Radiation in Stage IV Differentiated Thyroid Carcinoma.
    Yang Z, Flores J, Katz S, Nathan CA, Mehta V.
    Thyroid; 2017 Jul; 27(7):944-952. PubMed ID: 28446057
    [Abstract] [Full Text] [Related]

  • 10. Distribution of Na+/I- symporter in thyroid cancers in an iodine-deficient population: an immunohistochemical study.
    Mishra A, Pal L, Mishra SK.
    World J Surg; 2007 Sep; 31(9):1737-1742. PubMed ID: 17653791
    [Abstract] [Full Text] [Related]

  • 11. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
    Hiltzik D, Carlson DL, Tuttle RM, Chuai S, Ishill N, Shaha A, Shah JP, Singh B, Ghossein RA.
    Cancer; 2006 Mar 15; 106(6):1286-95. PubMed ID: 16470605
    [Abstract] [Full Text] [Related]

  • 12. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW, Brierley JD, Simpson WJ, Panzarella T, Gospodarowicz MK, Sutcliffe SB.
    Cancer; 1998 Jan 15; 82(2):375-88. PubMed ID: 9445196
    [Abstract] [Full Text] [Related]

  • 13. Follicular variant of papillary thyroid carcinoma is a unique clinical entity: a population-based study of 10,740 cases.
    Yu XM, Schneider DF, Leverson G, Chen H, Sippel RS.
    Thyroid; 2013 Oct 15; 23(10):1263-8. PubMed ID: 23477346
    [Abstract] [Full Text] [Related]

  • 14. Clinicopathologic Features of Fatal Non-Anaplastic Follicular Cell-Derived Thyroid Carcinomas.
    Xu B, Ibrahimpasic T, Wang L, Sabra MM, Migliacci JC, Tuttle RM, Ganly I, Ghossein R.
    Thyroid; 2016 Nov 15; 26(11):1588-1597. PubMed ID: 27480016
    [Abstract] [Full Text] [Related]

  • 15. Prognostic Impact of the Turin Criteria in Poorly Differentiated Thyroid Carcinoma.
    Akaishi J, Kondo T, Sugino K, Ogimi Y, Masaki C, Hames KY, Yabuta T, Tomoda C, Suzuki A, Matsuzu K, Uruno T, Ohkuwa K, Kitagawa W, Nagahama M, Katoh R, Ito K.
    World J Surg; 2019 Sep 15; 43(9):2235-2244. PubMed ID: 31098668
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
    Loh KC, Greenspan FS, Gee L, Miller TR, Yeo PP.
    J Clin Endocrinol Metab; 1997 Nov 15; 82(11):3553-62. PubMed ID: 9360506
    [Abstract] [Full Text] [Related]

  • 18. Differentiated thyroid cancer: a retrospective analysis of 832 cases from Greece.
    Tzavara I, Vlassopoulou B, Alevizaki C, Koukoulis G, Tzanela M, Koumoussi P, Sotsiou F, Thalassinos N.
    Clin Endocrinol (Oxf); 1999 May 15; 50(5):643-54. PubMed ID: 10468931
    [Abstract] [Full Text] [Related]

  • 19. [Differentiated thyroid carcinoma: prognostic factors].
    Györy F, Lukács G, Nagy EV, Juhász F, Mezösi E, Szakáll S, Máth J, Balázs G.
    Magy Seb; 2001 Apr 15; 54(2):69-74. PubMed ID: 11339092
    [Abstract] [Full Text] [Related]

  • 20. Oncocytic Papillary Thyroid Carcinoma and Oncocytic Poorly Differentiated Thyroid Carcinoma: Clinical Features, Uptake, and Response to Radioactive Iodine Therapy, and Outcome.
    Lukovic J, Petrovic I, Liu Z, Armstrong SM, Brierley JD, Tsang R, Pasternak JD, Gomez-Hernandez K, Liu A, Asa SL, Mete O.
    Front Endocrinol (Lausanne); 2021 Apr 15; 12():795184. PubMed ID: 34975765
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.